Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma

International Journal of Molecular Medicine

Volumn 26, Issue 2, 2010, Pages 281-288

  Gaida, Matthias M ^a   Haag, Natascha ^b   Günther, Frank ^b   Tschaharganeh, Darjus F ^a   Schirmacher, Peter ^a   Friess, Helmut ^c   Giese, Nathalia A ^b   Schmidt, Jan ^b   Wente, Moritz N ^b  

^a Institute of Pathology   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

A disintegrin and metalloprotease 10; Invasiveness; Migration; Pancreatic carcinoma

Indexed keywords

ADAM10 ENDOPEPTIDASE; MATRIGEL; MESSENGER RNA; SMALL INTERFERING RNA; UVOMORULIN; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; CADHERIN; MEMBRANE PROTEIN; SECRETASE;

ARTICLE; CANCER CELL; CANCER INVASION; CELL GROWTH; CELL MIGRATION; CELL VIABILITY; CHRONIC PANCREATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; PANCREAS CARCINOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; CARCINOMA; CELL LINE; CELL MOTION; CELL PROLIFERATION; GENETICS; METABOLISM; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; CADHERINS; CARCINOMA; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MEMBRANE PROTEINS; PANCREATIC NEOPLASMS; PANCREATITIS, CHRONIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 77955730220     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000463     Document Type: Article

References (56)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225-249, 2009.
2. Ringel J, Jesnowski R, Moniaux N, et al: Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma. Cancer Res 66: 9045-9053, 2006. (Pubitemid 44521123)
3. Valkovskaya N, Kayed H, Felix K, et al: ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer. J Cell Mol Med 11: 1162-1174, 2007. (Pubitemid 350037057)
4. Gould RJ, Polokoff MA, Friedman PA, Huang TF, Holt JC, Cook JJ and Niewiarowski S: Disintegrins: a family of integrin inhibitory proteins from viper venoms. Proc Soc Exp Biol Med 195: 168-171, 1990.
5. Kheradmand F and Werb Z: Shedding light on sheddases: role in growth and development. Bioessays 24: 8-12, 2002. (Pubitemid 34108414)
6. Blobel CP: ADAMs: key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32-43, 2005.
7. Seals DF and Courtneidge SA: The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17: 7-30, 2003.
8. Yuan R, Primakoff P and Myles DG: A role for the disintegrin domain of cyritestin, a sperm surface protein belonging to the ADAM family, in mouse sperm-egg plasma membrane adhesion and fusion. J Cell Biol 137: 105-112, 1997. (Pubitemid 27167299)
9. Eto K, Huet C, Tarui T, et al: Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions. J Biol Chem 277: 17804-17810, 2002.
10. Gilpin BJ, Loechel F, Mattei MG, Engvall E, Albrechtsen R and Wewer UM: A novel, secreted form of human ADAM 12 (meltrin alpha) provokes myogenesis in vivo. J Biol Chem 273: 157-166, 1998. (Pubitemid 28042189)
11. Kawaguchi N, Xu X, Tajima R, et al: ADAM 12 protease induces adipogenesis in transgenic mice. Am J Pathol 160: 1895-1903, 2002.
12. Masaki M, Kurisaki T, Shirakawa K and Sehara-Fujisawa A: Role of meltrin alpha (ADAM12) in obesity induced by high-fat diet. Endocrinology 146: 1752-1763, 2005.
13. Yang P, Baker KA and Hagg T: The ADAMs family: coordinators of nervous system development, plasticity and repair. Prog Neurobiol 79: 73-94, 2006. (Pubitemid 44247280)
14. Garton KJ, Gough PJ and Raines EW: Emerging roles for ectodomain shedding in the regulation of inflammatory responses. J Leukoc Biol 79: 1105-1116, 2006.
15. Holgate ST, Yang Y, Haitchi HM, et al: The genetics of asthma: ADAM33 as an example of a susceptibility gene. Proc Am Thorac Soc 3: 440-443, 2006.
16. Mochizuki S and Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sci 98: 621-628, 2007. (Pubitemid 46563436)
17. Chantry A, Gregson NA and Glynn P: A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. J Biol Chem 264: 21603-21607, 1989.
18. McCulloch DR, Akl P, Samaratunga H, Herington AC and Odorico DM: Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res 10: 314-323, 2004.
19. Black RA, Rauch CT, Kozlosky CJ, et al: A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729-733, 1997.
20. Lunn CA, Fan X, Dalie B, Miller K, Zavodny PJ, Narula SK and Lundell D: Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. FEBS Lett 400: 333-335, 1997. (Pubitemid 27039378)
21. Hundhausen C, Misztela D, Berkhout TA, et al: The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102: 1186-1195, 2003.
22. Schulte A, Schulz B, Andrzejewski MG, et al: Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases. Biochem Biophys Res Commun 358: 233-240, 2007.
23. Abel S, Hundhausen C, Mentlein R, et al: The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J Immunol 172: 6362-6372, 2004.
24. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ and Raines EW: A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 172: 3678-3685, 2004. (Pubitemid 38337951)
25. Gutwein P, Mechtersheimer S, Riedle S, et al: ADAM10- mediated cleavage of L1 adhesion molecule at the cell surface and in released membrane vesicles. FASEB J 17: 292-294, 2003.
26. Uemura K, Kihara T, Kuzuya A, et al: Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci Lett 402: 278-283, 2006.
27. Maretzky T, Reiss K, Ludwig A, et al: ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc Natl Acad Sci USA 102: 9182-9187, 2005.
28. Ko SY, Lin SC, Wong YK, Liu CJ, Chang KW and Liu TY: Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett 245: 33-43, 2007. (Pubitemid 46001499)
29. Fogel M, Gutwein P, Mechtersheimer S, et al: L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875, 2003.
30. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T and Ben-Ze'ev A: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168: 633-642, 2005.
31. Otto T, Rembrink K, Goepel M, Meyer-Schwickerath M and Rubben H: E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma. Urol Res 21: 359-362, 1993. (Pubitemid 23305755)
32. Yonemura Y, Ninomiya I, Kaji M, et al: Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol 8: 177-190, 1995.
33. Ryniers F, Stove C, Goethals M, et al: Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion. Biol Chem 383: 159-165, 2002.
34. Grutzmann R, Luttges J, Sipos B, et al: ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. Br J Cancer 90: 1053-1058, 2004.
35. Yamada D, Ohuchida K, Mizumoto K, et al: Increased expression of ADAM 9 and ADAM 15 mRNA in pancreatic cancer. Anticancer Res 27: 793-799, 2007. (Pubitemid 46586983)
36. Erkan M, Kleeff J, Esposito I, et al: Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene 24: 4421-4432, 2005.
37. Tousseyn T, Thathiah A, Jorissen E, et al: ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J Biol Chem 284: 11738-11747, 2009.
38. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C and Ullrich A: EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 1999. (Pubitemid 129515992)
39. Yan Y, Shirakabe K and Werb Z: The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J Cell Biol 158: 221-226, 2002.
40. Hinkle CL, Mohan MJ, Lin P, Yeung N, Rasmussen F, Milla ME and Moss ML: Multiple metalloproteinases process protransforming growth factor-alpha (proTGF-alpha). Biochemistry 42: 2127-2136, 2003.
41. Sahin U, Weskamp G, Kelly K, et al: Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J Cell Biol 164: 769-779, 2004.
42. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R and Ben-Ze'ev A: The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527, 1999. (Pubitemid 29234650)
43. Schramme A, Abdel-Bakky MS, Kampfer-Kolb N, Pfeilschifter J and Gutwein P: The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells. Biochem Biophys Res Commun 370: 311-316, 2008.
44. Hotary K, Allen E, Punturieri A, Yana I and Weiss SJ: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149: 1309-1323, 2000. (Pubitemid 30399683)
45. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW and Weiss SJ: Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114: 33-45, 2003.
46. Wolfsberg TG, Primakoff P, Myles DG and White JM: ADAM, a novel family of membrane proteins containing A Disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 131: 275-278, 1995.
47. Black RA and White JM: ADAMs: focus on the protease domain. Curr Opin Cell Biol 10: 654-659, 1998.
48. Rocks N, Paulissen G, El Hour M, et al: Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 90: 369-379, 2008.
49. Cheng M, Watson PH, Paterson JA, Seidah N, Chretien M and Shiu RP: Pro-protein convertase gene expression in human breast cancer. Int J Cancer 71: 966-971, 1997. (Pubitemid 27252877)
50. Page RE, Klein-Szanto AJ, Litwin S, et al: Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell Oncol 29: 289-299, 2007.
51. Bassi DE, Mahloogi H, Al-Saleem L, Lopez De CR, Ridge JA and Klein-Szanto AJ: Elevated furin expression in aggressive human head and neck tumors and tumor cell lines. Mol Carcinog 31: 224-232, 2001.
52. Zhou DC, Zittoun R and Marie JP: Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia. Leukemia 9: 1661-1666, 1995.
53. Matthews V, Schuster B, Schutze S, et al: Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE). J Biol Chem 278: 38829-38839, 2003.
54. Maretzky T, Schulte M, Ludwig A, et al: L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol Cell Biol 25: 9040-9053, 2005. (Pubitemid 41429092)
55. Wente MN, Gaida MM, Mayer C, et al: Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Int J Oncol 33: 297-308, 2008.
56. Gaida MM, Gunther F, Wagner C, et al: Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections. Clin Exp Immunol 154: 216-223, 2008.